These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14533030)

  • 1. The roles of T-lymphocyte subpopulations (CD4 and CD8), intercellular adhesion molecule-1 (ICAM-1), HLA-DR receptor, and mast cells in etiopathogenesis of pterygium.
    Beden U; Irkeç M; Orhan D; Orhan M
    Ocul Immunol Inflamm; 2003 Jun; 11(2):115-22. PubMed ID: 14533030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometrical analysis of adhesion molecules, T-lymphocyte subpopulations and inflammatory markers in pterygium.
    Tekelioglu Y; Turk A; Avunduk AM; Yulug E
    Ophthalmologica; 2006; 220(6):372-8. PubMed ID: 17095882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of T-lymphocyte subpopulations (CD4 and CD8) in pterygia: evaluation of the inflammatory response.
    Awdeh RM; DeStafeno JJ; Blackmon DM; Cummings TJ; Kim T
    Adv Ther; 2008 May; 25(5):479-87. PubMed ID: 18483701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR antigen expression in pterygium epithelial cells and lymphocyte subpopulations: an immunohistochemistry study.
    Ioachim-Velogianni E; Tsironi E; Agnantis N; Datseris G; Psilas K
    Ger J Ophthalmol; 1995 Mar; 4(2):123-9. PubMed ID: 7795511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of oral submucous fibrosis.
    Haque MF; Harris M; Meghji S; Speight PM
    J Oral Pathol Med; 1997 Feb; 26(2):75-82. PubMed ID: 9049906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical HLA-DR antigen expression with lymphocyte subsets and proliferative activity in pterygium.
    Tsironi S; Ioachim E; Machera M; Aspiotis M; Agnantis N; Psillas K
    In Vivo; 2002; 16(5):299-306. PubMed ID: 12494867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical studies from vitiligo--comparison between active and inactive lesions.
    Ahn SK; Choi EH; Lee SH; Won JH; Hann SK; Park YK
    Yonsei Med J; 1994 Dec; 35(4):404-10. PubMed ID: 7871844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
    Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
    J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory molecules in patients with gestational diabetes mellitus.
    Pendeloski KP; Mattar R; Torloni MR; Gomes CP; Alexandre SM; Daher S
    Endocrine; 2015 Sep; 50(1):99-109. PubMed ID: 25754913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ICAM-1 and HLA-DR by human conjunctival epithelial cultured cells and modulation by nedocromil sodium.
    Diebold Y; Calonge M; Carretero V; Fernández N; Herreras JM
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):517-31. PubMed ID: 9867335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease.
    Broomé U; Nemeth A; Hultcrantz R; Scheynius A
    J Hepatol; 1997 Apr; 26(4):857-62. PubMed ID: 9126800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular subsets and epithelial ICAM-1 and HLA-DR expression in human papillomavirus infection of the vulva.
    Morelli AE; Belardi G; DiPaola G; Paredes A; Fainboim L
    Acta Derm Venereol; 1994 Jan; 74(1):45-50. PubMed ID: 7908483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca.
    Pisella PJ; Brignole F; Debbasch C; Lozato PA; Creuzot-Garcher C; Bara J; Saiag P; Warnet JM; Baudouin C
    Ophthalmology; 2000 Oct; 107(10):1841-9. PubMed ID: 11013183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens.
    Limb GA; Franks WA; Munasinghe KR; Chignell AH; Dumonde DC
    Graefes Arch Clin Exp Ophthalmol; 1993 Jun; 231(6):331-6. PubMed ID: 8339948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps.
    Papon JF; Coste A; Gendron MC; Cordonnier C; Wingerstmann L; Peynègre R; Escudier E
    Laryngoscope; 2002 Nov; 112(11):2067-75. PubMed ID: 12439183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICAM-1 expression on the surface of T lymphocytes in patients with uveitis: a comparative study between the eye and peripheral blood.
    Martin CM; Santos Lacomba M; Serrano Molina CI; Ramirez Chamond R; Collantes Estevez E
    Ophthalmologica; 2002; 216(3):203-8. PubMed ID: 12065858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the normal conjunctival leukocyte population.
    Hingorani M; Metz D; Lightman SL
    Exp Eye Res; 1997 Jun; 64(6):905-12. PubMed ID: 9301471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.